Have your own idea? Try our Stock Screener
Argentinian (MERVAL) Pharma Industry Analysis
UpdatedJan 30, 2025
DataAggregated Company Financials
Companies2
- 7D-5.5%
- 3M-1.8%
- 1Y41.4%
- YTDn/a
Over the last 7 days, the Pharma industry has dropped 6.0%, driven by a pullback from Laboratorios RichmondC.I.F of 6.2%. In the past year, the industry has gained 63%.
Industry Valuation and Performance
Has the Argentinian Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 31 Jan 2025 | AR$135.1b | AR$42.6b | AR$18.2b | 6.2x | 7.4x | 3.2x |
| Sun, 29 Dec 2024 | AR$142.6b | AR$42.6b | AR$18.2b | 6.6x | 7.8x | 3.3x |
| Tue, 26 Nov 2024 | AR$155.2b | AR$42.6b | AR$18.2b | 6.7x | 8.5x | 3.6x |
| Thu, 24 Oct 2024 | AR$91.6b | AR$40.7b | AR$4.6b | 15.7x | 20.1x | 2.3x |
| Sat, 21 Sep 2024 | AR$78.5b | AR$40.7b | AR$4.6b | 12.8x | 17.2x | 1.9x |
| Mon, 19 Aug 2024 | AR$85.6b | AR$52.7b | AR$2.3b | 34.4x | 37.9x | 1.6x |
| Wed, 17 Jul 2024 | AR$78.5b | AR$41.1b | -AR$3,264,658,797.00 | 4.5x | -24x | 1.9x |
| Fri, 14 Jun 2024 | AR$86.1b | AR$41.1b | -AR$3,264,658,797.00 | 5x | -26.4x | 2.1x |
| Sun, 12 May 2024 | AR$77.3b | AR$43.6b | -AR$10,287,966,966.00 | 9.2x | -7.5x | 1.8x |
| Tue, 09 Apr 2024 | AR$77.8b | AR$9.6b | -AR$4,702,241,388.00 | 56.5x | -16.5x | 8.1x |
| Thu, 07 Mar 2024 | AR$68.0b | AR$9.6b | -AR$4,702,241,388.00 | 46.8x | -14.5x | 7x |
| Sat, 03 Feb 2024 | AR$96.6b | AR$10.3b | -AR$4,704,193,685.00 | 58.1x | -20.5x | 9.3x |
| Mon, 01 Jan 2024 | AR$59.1b | AR$10.3b | -AR$4,704,193,685.00 | 33.6x | -12.6x | 5.7x |
| Wed, 29 Nov 2023 | AR$60.8b | AR$9.7b | -AR$4,984,296,856.00 | n/a | -12.2x | 6.3x |
| Fri, 27 Oct 2023 | AR$58.8b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -23.5x | 4.5x |
| Sun, 24 Sep 2023 | AR$43.0b | AR$13.0b | -AR$2,496,856,221.00 | n/a | -17.2x | 3.3x |
| Tue, 22 Aug 2023 | AR$49.0b | AR$18.8b | -AR$150,001,147.00 | 15.4x | -326.6x | 2.6x |
| Thu, 20 Jul 2023 | AR$44.7b | AR$18.8b | -AR$150,001,147.00 | 13.7x | -298.1x | 2.4x |
| Sat, 17 Jun 2023 | AR$42.3b | AR$18.6b | -AR$173,562,384.00 | 19.5x | -243.8x | 2.3x |
| Mon, 15 May 2023 | AR$33.4b | AR$19.1b | AR$209.1m | 107.2x | 159.8x | 1.7x |
| Wed, 12 Apr 2023 | AR$32.3b | AR$19.1b | AR$209.1m | 103.6x | 154.6x | 1.7x |
| Fri, 10 Mar 2023 | AR$28.8b | AR$13.7b | AR$1.5b | 16.1x | 18.6x | 2.1x |
| Sun, 05 Feb 2023 | AR$32.3b | AR$13.7b | AR$1.5b | 17.4x | 20.9x | 2.4x |
| Tue, 03 Jan 2023 | AR$32.4b | AR$13.8b | AR$1.5b | 21.2x | 21.6x | 2.3x |
| Thu, 01 Dec 2022 | AR$27.5b | AR$19.6b | AR$1.4b | 19.8x | 20.2x | 1.4x |
| Sat, 29 Oct 2022 | AR$28.0b | AR$19.7b | AR$1.4b | 23.3x | 20.3x | 1.4x |
| Mon, 26 Sep 2022 | AR$24.9b | AR$19.7b | AR$1.4b | 24.3x | 18x | 1.3x |
| Wed, 24 Aug 2022 | AR$21.8b | AR$17.8b | AR$987.0m | 26x | 22.1x | 1.2x |
| Fri, 22 Jul 2022 | AR$21.0b | AR$17.6b | AR$940.9m | 21.2x | 22.4x | 1.2x |
| Sun, 19 Jun 2022 | AR$20.0b | AR$9.9b | AR$101.3m | 150.6x | 197x | 2x |
| Tue, 17 May 2022 | AR$19.4b | AR$9.9b | AR$101.3m | 145.6x | 191.3x | 1.9x |
| Thu, 14 Apr 2022 | AR$18.7b | AR$9.9b | AR$101.3m | 141.4x | 185x | 1.9x |
| Sat, 12 Mar 2022 | AR$21.2b | AR$9.9b | AR$101.3m | 159.3x | 209.1x | 2.1x |
| Mon, 07 Feb 2022 | AR$20.4b | AR$9.9b | AR$101.3m | 152.6x | 201.7x | 2.1x |
Price to Earnings Ratio
201.7x
Current Industry PE
- There are only 2 companies in the Argentinean Pharmaceuticals industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 464% per year over the last three years.
- Revenues for these companies have grown 62% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Argentinian Pharma compare with similar industries?
| AR Market | -5.04% | |
| Healthcare | -5.53% | |
| Pharma | -5.53% | |
| Pharma | -5.53% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROSE Instituto Rosenbusch | AR$115.00 | 6.5% +AR$298.1m | 6.5% | PE4.9x |